Nanoparticle delivery systems for cancer therapy: advances in clinical and preclinical research.
about
Human Papillomavirus: Current and Future RNAi Therapeutic Strategies for Cervical CancerSilk fibroin-based nanoparticles for drug deliveryNano/microparticles and ultrasound contrast agentsLiposomal Formulations in Clinical Use: An Updated Review.Use of Nanotechnology to Develop Multi-Drug Inhibitors For Cancer TherapyEnhanced Bioactivity of α-Tocopheryl Succinate Based Block Copolymer Nanoparticles by Reduced Hydrophobicity.Bioengineering strategies for designing targeted cancer therapiesPaclitaxel-incorporated nanoparticles using block copolymers composed of poly(ethylene glycol)/poly(3-hydroxyoctanoate).In vitro and in vivo anti-cancer effects of targeting and photothermal sensitive solid lipid nanoparticles.Ligand-targeted theranostic nanomedicines against cancerImprovement and enhancement of antibladder carcinoma cell effects of heteronemin by the nanosized hyaluronan aggregation.Analyzing collaboration networks and developmental patterns of nano-enabled drug delivery (NEDD) for brain cancer.Advanced targeted nanomedicineA Novel Approach on Drug Delivery: Investigation of A New Nano-Formulation of Liposomal Doxorubicin and Biological Evaluation of Entrapped Doxorubicin on Various Osteosarcoma Cell Lines.Accumulation and toxicity of antibody-targeted doxorubicin-loaded PEG-PE micelles in ovarian cancer cell spheroid model.Micromixer Based Preparation of Functionalized Liposomes and Targeting Drug Delivery.Protocells: Modular Mesoporous Silica Nanoparticle-Supported Lipid Bilayers for Drug Delivery.Pamidronate functionalized nanoconjugates for targeted therapy of focal skeletal malignant osteolysis.The functional role of MnSOD as a biomarker of human diseases and therapeutic potential of a new isoform of a human recombinant MnSODGold Nanoparticle Approach to the Selective Delivery of Gene Silencing in Cancer-The Case for Combined Delivery?Oxidative stress in apoptosis and cancer: an update.Current trends in the use of liposomes for tumor targetingNanoparticles targeting mechanisms in cancer therapy: current limitations and emerging solutions.Recent developments in liposome-based veterinary therapeutics.The Use of Anthracyclines for Therapy of CNS Tumors.Expansile crosslinked polymersomes for pH sensitive delivery of doxorubicin.Formulation and physiologic factors affecting the pharmacology of carrier-mediated anticancer agents.Nanotechnology: History and future.In Vitro Study of Influence of Au Nanoparticles on HT29 and SPEV Cell Lines.Challenges in preclinical to clinical translation for anticancer carrier-mediated agents.Preclinical Safety Evaluation in Rats of a Polymeric Matrix Containing an siRNA Drug Used as a Local and Prolonged Delivery System for Pancreatic Cancer Therapy.Hyaluronan-decorated polymer nanoparticles targeting the CD44 receptor for the combined photo/chemo-therapy of cancer.Hepatic Stellate Cells in Liver Fibrosis and siRNA-Based Therapy.Trends on polymer- and lipid-based nanostructures for parenteral drug delivery to tumors.Diagnostic nanoparticle targeting of the EGF-receptor in complex biological conditions using single-domain antibodies.Biodegradable Polymersomes as Nanocarriers for Doxorubicin Hydrochloride: Enhanced Cytotoxicity in MCF-7/ADR Cells and Prolonged Blood Circulation.Complexation of cell-penetrating peptide-polymer conjugates with polyanions controls cells uptake of HPMA copolymers and anti-tumor activity.In vitro and in vivo evaluation of lipofufol, a new triple stealth liposomal formulation of modulated 5-fu: impact on efficacy and toxicity.Development of siRNA lipoplexes for intracellular delivery in lung cancer cellsRecent developments in nanoparticle-based siRNA delivery for cancer therapy.
P2860
Q26799484-6413EB86-5B74-42E3-8511-EDDE42753A75Q26995026-FA9FBD8E-E851-4669-B67D-5F70C684EEFEQ30445347-563D94A3-C995-4F72-933C-96E7ADDE6F23Q33850427-895B45E2-8B34-4CF1-BF3D-1058BC488706Q33859472-F724EF28-B474-4818-9EF1-00D54299E9F3Q33920277-402E960D-5646-4CD3-83B5-0C3EADEC9549Q34194191-F6DBCEF3-6EDE-4812-AAB6-237F2BB7F597Q34286120-ED478C5B-6010-4894-A65B-44B2FE75ED66Q35194733-334866D7-7D94-400E-8284-1C3183F674F7Q35895637-C49EF519-EA4F-4F28-855C-DFF63012883CQ35995448-7E800017-D7D3-4637-AC59-557FAE03257EQ36081996-5C9E9F6B-A9CA-4389-86D1-CDA30997FBF0Q36388931-F312E717-3067-4425-9748-F517383A10C7Q36392418-2BCB0C73-4A02-44AD-BDE7-79BB2A0F99A7Q36412928-730E79CD-FCCF-471E-A23D-C5CFC0197E69Q36806767-48508D0B-2E60-47CD-9DA7-C6C60E0F4B0BQ37134029-1681466B-CA8C-42D7-8EFC-7B6543F9F882Q37181752-960E50FB-BFFD-412A-AC20-57B4BEF3122CQ37552213-210DD7CB-C98D-4FF4-930D-FA4BD29AD1EDQ37724113-B231C698-7053-486E-97AF-2FC6A01E17EAQ38027434-C166EDA7-85FA-4FB6-99F3-150533FCD1F7Q38126543-5D827862-8365-4060-BE62-65FEF0CF0A5DQ38136246-65F9570E-EBBC-4D3C-B97C-1558BC58D58DQ38162184-8ACB8D6F-32F0-4E83-A536-343CD32DAD3DQ38407992-CE5836FB-4006-4C5B-8A4E-1EDE6F4DFD41Q38544183-1FABEAC3-FA42-4C3E-A657-74A6B970783CQ38546964-17F39190-03F5-481F-90BD-C8B3117BC048Q38651285-8BED15D3-6D24-49E8-8580-9CAF503CD85AQ38694807-76CBCDF2-3664-4C84-A656-AE55CF624D0BQ38723333-F5EED3D2-19DE-4BF6-92FB-FDCA625D2BE2Q38871344-4C7B43E4-FFF8-4173-BC9A-CFC3C4B3DF85Q38913276-A8AD1F71-84AA-46F5-9815-90F57783DD8BQ38930049-CFB7E761-198A-41CA-9E9C-977781073102Q38981743-877DB3A3-A3A0-4768-978D-97B85F2AC72AQ39000589-8F42AD04-2958-44FB-854D-123CEB8F9573Q39076083-575F6F86-E867-4DD2-AFB0-AC21E9C68136Q39098106-0AA069CC-20BB-4EDF-93FC-C2A1CCF76869Q39198848-7612684F-E23F-419A-A66D-6AB4BD47C1B2Q39259146-CEEE6475-30F5-4307-8D3F-D834B60DBFCFQ39386763-575D3FC2-2F01-4818-AF7E-9106FEB1359C
P2860
Nanoparticle delivery systems for cancer therapy: advances in clinical and preclinical research.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Nanoparticle delivery systems ...... ical and preclinical research.
@en
Nanoparticle delivery systems ...... ical and preclinical research.
@nl
type
label
Nanoparticle delivery systems ...... ical and preclinical research.
@en
Nanoparticle delivery systems ...... ical and preclinical research.
@nl
prefLabel
Nanoparticle delivery systems ...... ical and preclinical research.
@en
Nanoparticle delivery systems ...... ical and preclinical research.
@nl
P2860
P1476
Nanoparticle delivery systems ...... nical and preclinical research
@en
P2093
José Luis Pedraz
Susana Patricia Egusquiaguirre
P2860
P2888
P356
10.1007/S12094-012-0766-6
P577
2012-02-01T00:00:00Z